F8 and hemophilia: Third, underlying haemophilia genotype has been associated with the risk of anti-FVIII inhibitor development [26-28] and the probability of ITI success [29,30]; most patients with large deletions undergoing ITI fail to respond whereas patients with int22inv have an intermediate and variable success rate.